I read the release about the Gilead trials. IMO it looks like initially there might eventually be a tiered approach with a couple of drugs administered in a combination treatment. If Lironlimab is included in that cocktail of drugs, that's probably ok initially. That gives an opportunity to treat ill patients and hopefully it will then come to light that patients can be treated with just Leronlimab with little safety concerns. Do what needs to be done to get the drug in the hands of people that need it.

I wonder if physicians that refuse to give patients the opportunity to try treatment with Linronlimab may be having an impact on enrollment?

I'm an avid supporter of where we are headed and in for the long haul.